CSS LLC’s Haemonetics HAE Stock Holding History

CSS LLC’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$375K	Buy	+5,000	New	+$321K	0.01%	629

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CSS LLC's HAE Position: Q2 2026 in Review

CSS LLC reduced its Haemonetics (HAE) stake by 29% in Q2 2026, selling an estimated $380K and leaving 14,810 shares worth $1.11M. The position accounts for 0.04% of the portfolio, ranked #318.

CSS LLC first reported a position in HAE in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.17M in Q1 2026. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

CSS LLC held 14,810 shares of Haemonetics worth $1.11M as of Q2 2026.
CSS LLC sold 5,911 Haemonetics shares in Q2 2026, an estimated $380K.
Haemonetics made up 0.04% of CSS LLC's portfolio in Q2 2026, its #318 holding.
CSS LLC first reported a position in Haemonetics in Q1 2026 and has held it in 2 quarters since.
CSS LLC's Haemonetics position peaked at $1.17M in Q1 2026.
329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on CSS LLC's 13F filing for Q2 2026, filed 14 Aug 2026.